APA (7th ed.) Citation

Argyriou, A. A., Karteri, S., Bruna, J., Mariotto, S., Simo, M., Velissaris, D., . . . Kalofonos, H. P. (2022). Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: A prospective study. Supportive care in cancer, 30(2), 1807-1814. https://doi.org/10.1007/s00520-021-06509-x

Chicago Style (17th ed.) Citation

Argyriou, Andreas A., et al. "Serum Neurofilament Light Chain Levels as Biomarker of Paclitaxel-induced Cognitive Impairment in Patients with Breast Cancer: A Prospective Study." Supportive Care in Cancer 30, no. 2 (2022): 1807-1814. https://doi.org/10.1007/s00520-021-06509-x.

MLA (9th ed.) Citation

Argyriou, Andreas A., et al. "Serum Neurofilament Light Chain Levels as Biomarker of Paclitaxel-induced Cognitive Impairment in Patients with Breast Cancer: A Prospective Study." Supportive Care in Cancer, vol. 30, no. 2, 2022, pp. 1807-1814, https://doi.org/10.1007/s00520-021-06509-x.